Filing: Oura is seeking to raise up to $2.2B in its US IPO, marketing 50M shares at $40 to $44 each, giving it a $14.1B valuation at the top of its price range
Context & Ripple Effects
Oura’s path to public markets moved from a reported confidential IPO filing in May to a September registration that disclosed $1.21B in nine-month revenue alongside a $924.3M net loss. The proposed range gives investors a concrete valuation framework for weighing that growth and loss profile.
Earlier reports that Oura and its backers sought as much as $3B at a valuation above $16B were unconfirmed. The formal terms instead set out a raise of up to $2.2B and a top-range valuation of $14.1B.
First-order effects
- Oura can market 50M shares at $40 to $44, putting up to $2.2B of IPO proceeds and a $14.1B top-range valuation before prospective public investors.
- The offering turns the financial disclosures in Oura’s September IPO filing into an investable price decision rather than a private-market valuation discussion.
Second-order effects
- Oura’s existing backers and prospective buyers gain a public reference point for liquidity and valuation, replacing the higher, unconfirmed private-market fundraising target with disclosed offering terms.
- The IPO’s reception will make Oura’s revenue growth and widening net loss the central terms on which public investors assess the company’s proposed valuation.
Third-order effects
- If issuers continue moving from confidential filings to tightly specified price ranges, public IPO marketing will increasingly serve as the test of whether private valuations can convert into liquid market prices.
The trend: Oura’s offering is part of the shift from private-company valuation narratives to public-market price discovery through formally marketed IPOs.